Evaluation of virtual screening as a tool for chemical genetic applications

Journal of Chemical Information and Modeling

Volumn 49, Issue 9, 2009, Pages 2082-2091

  Valérie, Campagna Slater ^a   Schapira, Matthieu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SYSTEMS; DIGITAL LIBRARIES; GENES;

BIOLOGICAL FUNCTIONS; COMPOUND LIBRARIES; GENETIC APPLICATIONS; HISTONE ACETYLTRANSFERASES; HISTONE METHYLTRANSFERASE; NUCLEAR HORMONE RECEPTOR; PROTEIN TARGETS; VIRTUAL SCREENING;

BINDING SITES;

CELL RECEPTOR; ENZYME INHIBITOR; HISTONE; SULFOTRANSFERASE;

ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER INTERFACE; DRUG ANTAGONISM; DRUG SCREENING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROTEIN CONFORMATION;

COMPUTATIONAL BIOLOGY; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; GENETICS; HISTONES; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SULFOTRANSFERASES; USER-COMPUTER INTERFACE;

EID: 70349926025     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci900219u     Document Type: Article

References (36)

1. Mayer, T. U.; Kapoor, T. M.; Haggarty, S. J.; King, R. W.; Schreiber, S. L.; Mitchison, T. J. Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen. Science 1999, 286, 971-974.
2. Wu, X.; Ding, S.; Ding, Q.; Gray, N. S.; Schultz, P. G. A Small Molecule with Osteogenesis-Inducing Activity in Multipotent Mesenchymal Progenitor Cells. J. Am. Chem. Soc. 2002, 124, 14520-14521.
3. Schreiber, S. L. Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery. Science 2000, 287, 1964-1969.
4. Kuruvilla, F. G.; Shamji, A. F.; Sternson, S. M.; Hergenrother, P. J.; Schreiber, S. L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 2002, 416, 653-657.
5. Strausberg, R. L.; Schreiber, S. L. From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes. Science 2003, 300, 294-295.
6. Huryn, D. M.; Cosford, N. D. P. The Molecular Libraries Screening Center Network (MLSCN): Identifying Chemical Probes of Biological Systems. Annu. Rep. Med. Chem. 2007, 42, 401-416.
7. Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.; Irwin, J. J.; Shoichet, B. K. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 2007, 25, 197-206.
8. Hert, J.; Keiser, M. J.; Irwin, J. J.; Oprea, T. I.; Shoichet, B. K. Quantifying the relationships among drug classes. J. Chem. Inf. Model. 2008, 48, 755-765.
9. Najmanovitch, R.; Allali-Hassani, A.; Morris, R. J.; Dombrovski, L.; Pan, P. W.; Vedadi, M.; Plotnikov, A. N.; Edwards, A.; Arrowsmith, C. H.; Thornton, J. M. Analysis of binding site similarity, small- molecule similarity and experimental binding profiles in the human cytosolic sulfotransferase family. Bioinformatics 2007, 23, e104-109.
10. Macchiarulo, A.; Nobeli, I.; Thornton, J. M. Ligand selectivity and competition between enzymes in silico. Nat. Biotechnol. 2004, 22, 1039-1045.
11. Bisson, W. H.; Cheltsov, A. V.; Bruey-Sedano, N.; Lin, B.; Chen, J.; Goldberger, N.; May, L. T.; Christopoulos, A.; Dalton, J. T.; Sexton, P. M.; Zhang, X. -K.; Abagyan, R. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc. Nat. Acad. Sci. U.S.A. 2007, 104, 11927-11932.
12. Kalyanaraman, C.; Bernacki, K.; Jacobson, M. P. Virtual Screening against Highly Charged Active Sites: Indentifying Substrates of Alpha- Beta Barrel Enzymes. Biochemistry 2005, 44, 2059-2071.
13. Hermann, J. C.; Ghanem, E.; Li, Y.; Raushel, F. M.; Irwin, J. J.; Shoichet, B. K. Predicting Substrates by Docking High-Energy Intermediates to Enzyme Structures. J. Am. Chem. Soc. 2006, 128, 15882-15891.
14. Song, L.; Kalyanaraman, C.; Fedorov, A. A.; Fedorov, E. V.; Glasner, M. E.; Brown, S.; Imker, H. J.; Babbitt, P. C.; Almo, S. C.; Jacobson, M. P.; Gerlt, J. A. Prediction and assignment of function for a divergent N-succinyl amino acid racemase. Nat. Chem. Biol. 2007, 8, 486-491.
15. Hermann, J. C.; Marti-Arbona, R.; Fedorov, A. A.; Fedorov, E.; Almo, S. C.; Shoichet, B. K.; Raushel, F. M. Structure-based activity prediction for an enzyme of unknown function. Nature 2007, 448, 775-781.
16. Kalyanaraman, C.; Imker, H. J.; Fedorov, A. A.; Fedorov, E. V.; Glasner, M. E.; Babbitt, P. C.; Almo, S. C.; Gerlt, J. A.; Jacobson, M. P. Discovery of a Dipeptide Epimerase Enzymatic Function Guided by Homology Modeling and Virtual Screening. Structure 2008, 16, 1668-1677.
17. Cross, J. B.; Thompson, D. C.; Rai, B. K.; Baber, J. C.; Fan, K. Y. Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy. J. Chem. Inf. Model. 2009, 49, 1455-1474.
18. Gamage, N.; Barnett, A.; Hempel, N.; Duggleby, R. G.; Windmill, K. F.; Martin, J. L.; McManus, M. E. Human Sulfotransferases and Their Role in Chemical Metabolism. Toxicol. Sci. 2006, 90, 5-22.
19. ICM 3. 6 Manual; Molsoft LLC: San Diego, CA. www.molsoft.com (accessed July 3, 2008).
20. Abagyan, R. A.; Totrov, M. M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 1994, 235, 983-1002.
21. Kouzarides, T. Chromatin Modifications and Their Function. Cell 2007, 128, 693-705.
22. Berndsen, C. E.; Denu, J. M. Catalysis and substrate selection by histone/protein lysine acetyltransferases. Curr. Opin. Struct. Biol 2008, 18, 682-689.
23. Cole, P. A. Chemical probes for histone-modifying enzymes. Nat. Chem. Biol. 2008, 4, 590-597.
24. Rich, D. H.; Moon, B. J.; Harbeson, S. Inhibition of Aminopeptidases by Amastatin and Bestatin Derivatives. Effect of Inhibitor Structure on Slow-Binding Processes. J. Med. Chem. 1984, 27, 417-422.
25. Aranda, A.; Pascual, A. Nuclear Hormone Receptors and Gene Expression. Physiol. Rev. 2001, 81, 1269-1304.
26. Staels, B. PPARgamma and atherosclerosis. Curr. Med. Res. Opin. 2005, 21, S13-20.
27. Lehrke, M.; Lazar, M. A. The Many Faces of PPAR. Cell 2005, 123, 993-999.
28. Das, S.; Schapira, M.; Tomic-Canic, M.; Goyanka, R.; Cardozo, T.; Samuels, H. H. Farnesyl Pyrophosphate Is a Novel Transcriptional Activator for a Subset of Nuclear Hormone Receptors. Mol. Endocrinol. 2007, 21, 2672-2686.
29. Wishart, D. S.; Knox, C.; Guo, A. C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006, 34, D668-672.
30. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. -A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; MacInnis, G. D.; Weljie, A. M.; Dowla- tabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007, 35, D521-526.
31. O'Connor, K. A.; Roth, B. L. Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery. Nat. Rev. Drug. Discovery 2005, 4, 1005-1014.
32. Shoichet, B. K. Virtual screening of chemical libraries. Nature 2004, 432, 862-865.
33. Waszkowycz, B. Towards improving compound selection in structure- based virtual screening. Drug Discovery Today 2008, 13, 219-226.
34. Pan, Y.; Huang, N.; Cho, S.; MacKerell, A. D. J. Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening. J. Chem. Inf. Comput. Sci. 2003, 43, 267-272.
35. Paolini, G. V.; Shapland, R. H.; Hoorn, W. P. V.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24, 805-815.
36. Schreiber, S. L. Small molecules: the missing link in the central dogma. Nat. Chem. Biol. 2005, 1, 64-66.